Elevance gains $190M on revised MA star ratings | Healthcare Dive
It’s a positive development for the insurer, which sued the government earlier this year after its quality scores fell dramatically.| Healthcare Dive
It’s a positive development for the insurer, which sued the government earlier this year after its quality scores fell dramatically.| Healthcare Dive
The insurer is actively seeking ways to mitigate the financial impact of its star ratings drop, Elevance CEO Gail Boudreaux said during the insurer’s third-quarter earnings call.| Healthcare Dive
The payer is taking issue with how regulators calculated quality scores for 2024, after seeing a stars decline that could cause its bonus revenue to fall by $500 million.| Healthcare Dive
The insurer argued the CMS didn’t follow its stated methodology for calculating quality scores, causing its rating to drop and risking millions of dollars in payments.| Healthcare Dive
The Medicare trustees’ new projection for insolvency is five years later than previous forecasts, but budget hawks warned action is still needed to shore up the insurance program’s finances.| Healthcare Dive
About 42% of Medicare Advantage plans that offer prescription drug coverage in 2024 earned four or more stars, compared with just over half this year.| Healthcare Dive
Volatility in MA stars for the 2023 plan year is raising questions around the earnings outlooks issued by payers.| Healthcare Dive
